GLA
IBB icon

Great Lakes Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Great Lakes Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,120
Closed -$943K – 593
2017
Q2 		$943K Buy
9,120
+270
+3% +$26.6K 0.02% 370
2017
Q1 		$865K Hold
8,850
– – 0.02% 375
2016
Q4 		$783K Sell
8,850
-600
-6% -$54.6K 0.02% 378
2016
Q3 		$912K Hold
9,450
– – 0.02% 364
2016
Q2 		$811K Buy
9,450
+1,272
+16% +$114K 0.02% 380
2016
Q1 		$711K Buy
+8,178
New +$731K 0.02% 396

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Great Lakes Advisors's IBB Position: Q3 2017 in Review

Great Lakes Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2017, closing a stake of 9,120 shares — an estimated $943K sold.

Great Lakes Advisors first reported a position in IBB in Q1 2016 and held it in 6 quarters. The position peaked at $943K in Q2 2017. 583 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • Great Lakes Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2017 after selling out during the quarter.
  • Great Lakes Advisors sold 9,120 iShares Biotechnology ETF shares in Q3 2017, an estimated $943K.
  • Great Lakes Advisors first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 6 quarters.
  • Great Lakes Advisors's iShares Biotechnology ETF position peaked at $943K in Q2 2017.
  • 583 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on Great Lakes Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.